Jefferies Assumes Alkermes (ALKS) at Buy
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $46.80 -1.29%
Rating Summary:
17 Buy, 8 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
17 Buy, 8 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Jefferies assumes coverage on Alkermes (NASDAQ: ALKS) with a Buy. PT $21.00.
The firm comments, "We think the merger w/ EDT still remains under-appreciated, as it 1)reduces a dependence on Risperdal Consta; 2) improves ALKS' profitability and margins, 3) lowers ALKS' tax rate; and 4) adds commercial/operational expertise."
For more ratings news on Alkermes click here and for the rating history of Alkermes click here.
Shares of Alkermes closed at $15.55 yesterday.
The firm comments, "We think the merger w/ EDT still remains under-appreciated, as it 1)reduces a dependence on Risperdal Consta; 2) improves ALKS' profitability and margins, 3) lowers ALKS' tax rate; and 4) adds commercial/operational expertise."
For more ratings news on Alkermes click here and for the rating history of Alkermes click here.
Shares of Alkermes closed at $15.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Gorilla Tech Group (GRRR) at Buy
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Jefferies
- Cantor Fitzgerald Starts Braveheart Bio (BRVE) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
